Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$0.89 - $2.36 $47,677 - $126,425
53,570 New
53,570 $47,000
Q3 2021

Oct 22, 2021

SELL
$10.18 - $26.64 $81,949 - $214,452
-8,050 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$18.57 - $35.68 $648,742 - $1.25 Million
-34,935 Reduced 81.27%
8,050 $214,000
Q1 2021

May 17, 2021

SELL
$31.0 - $55.72 $667,120 - $1.2 Million
-21,520 Reduced 33.36%
42,985 $1.49 Million
Q4 2020

Feb 26, 2021

BUY
$37.09 - $48.97 $1.35 Million - $1.78 Million
36,280 Added 128.54%
64,505 $2.39 Million
Q3 2020

Nov 12, 2020

SELL
$40.47 - $45.5 $1.71 Million - $1.92 Million
-42,275 Reduced 59.96%
28,225 $1.21 Million
Q3 2020

Nov 12, 2020

BUY
$40.47 - $45.5 $685,157 - $770,315
16,930 Added 31.6%
70,500 $2.9 Million
Q2 2020

Aug 18, 2020

BUY
$32.57 - $42.83 $825,486 - $1.09 Million
25,345 Added 89.8%
53,570 $2.17 Million
Q4 2019

Feb 11, 2020

BUY
$34.58 - $48.06 $102,529 - $142,497
2,965 Added 11.74%
28,225 $1.21 Million
Q3 2019

Nov 15, 2019

SELL
$36.98 - $48.45 $414,582 - $543,172
-11,211 Reduced 30.74%
25,260 $934,000
Q2 2019

Aug 14, 2019

BUY
$35.13 - $55.53 $20,586 - $32,540
586 Added 1.63%
36,471 $1.65 Million
Q1 2019

May 14, 2019

SELL
$42.83 - $59.91 $957,678 - $1.34 Million
-22,360 Reduced 38.39%
35,885 $1.95 Million
Q4 2018

Feb 13, 2019

BUY
$37.97 - $60.16 $293,508 - $465,036
7,730 Added 15.3%
58,245 $2.7 Million
Q3 2018

Nov 14, 2018

SELL
$56.3 - $67.25 $20,549 - $24,546
-365 Reduced 0.72%
50,515 $3.07 Million
Q2 2018

Aug 10, 2018

SELL
$44.9 - $64.95 $1.47 Million - $2.12 Million
-32,630 Reduced 39.07%
50,880 $3.19 Million
Q1 2018

May 17, 2018

BUY
$45.35 - $61.65 $1.94 Million - $2.64 Million
42,835 Added 105.31%
83,510 $3.86 Million
Q4 2017

Feb 15, 2018

SELL
$41.95 - $60.1 $2.14 Million - $3.06 Million
-50,925 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$33.4 - $53.9 $1.7 Million - $2.74 Million
50,925
50,925 $2.74 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Doheny Asset Management /Ca Portfolio

Follow Doheny Asset Management /Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.